5,401 results on '"Esophageal adenocarcinoma"'
Search Results
2. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib in Combination With Trastuzumab Deruxtecan or With Trastuzumab Emtansine and to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
3. Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery
4. A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers (HERIZON-GEA-01)
5. Phase II Trial of Neoadjuvant Pembrolizumab for Patients With Early Stage Gastroesophageal Adenocarcinoma
6. A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
7. A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
8. A Study of SGN-B6A in Advanced Solid Tumors
9. A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma (EMERALD)
10. RICE: Radio-Immuno-Chemotherapy of Cancer of the Esophagus (RICE)
11. Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
12. Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
13. Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
14. Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
15. Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
16. A Study of KK2269 in Adult Participants With Solid Tumors
17. (VELA) Study of BLU-222 in Advanced Solid Tumors
18. Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
19. The Microenvironment in Barrett's Esophagus (BETRNet2)
20. Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance (SWAT-BE)
21. Curative Resection of T1a Inlet Patch Adenocarcinoma With Traction-Assisted Endoscopic Submucosal Dissection.
22. Multiorgan Metabolic Imaging Response Assessment of Abemaciclib (MiMe-A)
23. Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
24. Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia (SURVENT)
25. Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans
26. Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer (PDL1x41BB)
27. Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
28. Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
29. Semaphorin 3F (SEMA3F) influences patient survival in esophageal adenocarcinoma.
30. The Public's Intended Uptake of Hypothetical Esophageal Adenocarcinoma Screening Scenarios: A Nationwide Survey.
31. Transcriptomic changes and gene fusions during the progression from Barrett's esophagus to esophageal adenocarcinoma.
32. Role of diet in the risks of esophageal adenocarcinoma and squamous cell carcinoma: an updated umbrella review.
33. Irregular Z-Line: To Biopsy or Not to Biopsy?
34. Definition of a Multi-Omics Signature for Esophageal Adenocarcinoma Prognosis Prediction.
35. Etiologic factors for Barrett's esophagus: toward countermeasures in Asia.
36. Improving esophageal cancer screening across the globe: Translating knowledge into action.
37. Fusobacterium Detected in Barrett's Esophagus and Esophageal Adenocarcinoma Tissues.
38. The Aberrant Expression of Biomarkers and Risk Prediction for Neoplastic Changes in Barrett's Esophagus–Dysplasia.
39. Dutch, UK and US professionals perceptions of screening for Barretts esophagus and esophageal adenocarcinoma: a concept mapping study.
40. Semaphorin 3F (SEMA3F) influences patient survival in esophageal adenocarcinoma
41. Transcriptomic changes and gene fusions during the progression from Barrett’s esophagus to esophageal adenocarcinoma
42. A rare case of tumor-to-tumor metastasis of esophageal adenocarcinoma into meningioma
43. Esophageal Cancer
44. Esophageal Diseases
45. Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas
46. Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer (CheckMate649)
47. Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material
48. Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
49. Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma
50. Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.